Stryker eyeing acquisitions

Orthopedic implant maker Stryker might tap its cash stockpile to purchase assets after completing its purchase of Boston Scientific's neurovascular unit, showing its willingness to diversify. Stryker has been buying a number of smaller companies recently, including the Sonopet ultrasonic device business, ulcer treatment maker Gaymar Industries and Porex Surgical products, Reuters notes. "All the big guys are looking for new avenues of growth," said Susquehanna analyst David Turkaly. "They have $2 billion in net cash that they are still sitting on, so I think you'll see them do more acquisitions." News

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.